• Seen : 1395 View
Rate :
  • Address : no 178-west hoveizeh st-sabunchi st-beheshty st-Tehran-Iran
  • About us : Zahrawi Pharmaceutical Company was founded in 1365 and with the commissioning of a factory with a total area of ​​120,000 square meters, an underground facility of 28,000 square meters was located near the dam of Tabriz in East Azarbaijan province in 1370.The company is committed to achieving health, longevity and prosperity with the goal of supplying the highest quality pharmaceutical n ...
    More
  • About us :

    Zahrawi Pharmaceutical Company was founded in 1365 and with the commissioning of a factory with a total area of ​​120,000 square meters, an underground facility of 28,000 square meters was located near the dam of Tabriz in East Azarbaijan province in 1370.
    The company is committed to achieving health, longevity and prosperity with the goal of supplying the highest quality pharmaceutical needs of the country, as well as opening up export markets using advanced technologies in production lines and product formulation, as well as controlling production processes in accordance with the latest global standards. Is now among the five leading pharmaceutical companies in the country and pioneers in the production of soft capsules, drugs used in organ transplantation, dialysis, biotechnology products and, finally, a ready-made syringe for copamemers for MS patients.

    The company's pharmaceutical products are available in different doses of soft capsules, pills, ampoules, hard gelatin capsules and injecting syringes, and now more than 100 products are produced and marketed in accordance with the principles of GMP to meet the needs of both domestic and foreign.

    Zahravi Pharmaceutical Company uses a complete evaluation system as the key to quality and provides seamless and day-to-day control of all stages of production from raw materials to finished products in quality control labs and quality assurance units.

    Zahrawi's research and development department is also responsible for research projects and all processes are designed and implemented based on the requirements (GMP) and rules (WHO).

    Zahrawi Pharmaceutical Company has been licensed under the license of F.Hoffman La ROCHE, Switzerland, for the prevention of transplant rejection in transplant patients, as well as Roacotane for the treatment of acne. The whole of the substance The first-site-equipment and pharmaceuticals are made in accordance with the requirements of the Swiss company Roche.

    Transplantation and dialysis drugs such as Cograto capsules (tacrolimus), soft-immunoral capsules (cyclosporine), and soft capsistriol capsules are also manufactured and supplied by Zahravi Pharmaceuticals. At present, Zahravi is one of the most important suppliers of transplant medications in Iran. Country is considered.

    The production of biotechnology products as injection molding syringes is also a recent achievement of the company, which is currently launching the beta-putein (erythropoietin beta) and soon-to-be-filtrated product.

    Zahrawi Pharmaceutical Company is committed to its rapid growth and development thanks to creativity, innovation and endless effort by its executives and its staff, which has given the same vitality and continuous effort to reach the pharmaceutical export markets faster than expected.

    The managerial vision of the managers and the honest efforts of the staff of Zahravi Pharmaceutical Company to improve the technology and the quality of the products-receive the ISO 9001 certificate for ISO 14001 quality management system, for the environmental management system and OHSAS 18001 for the occupational safety and health system. Has created a suitable place for participation in exhibitions and congresses both domestic and foreign.

    Zahrawi Pharmaceutical Company has launched various clinical studies on its own products, in order to attract the trust of doctors and pharmacists. Fortunately, the successful results of these clinical studies reflect the quality of the company's products. Also, in the schedule of visits to the factory of physicians and pharmacists closely acquainted with the production stages with precise controls and sensitivities of the company in the production of specialist drugs.

    Success in exporting manufactured products and gaining credibility by internationally acclaimed companies for joint projects and production under license for their products demonstrates the resolve of the Zahrawi Pharmaceutical Company to move towards sustainable development, among which the employee's health and happiness and ongoing efforts to promote science And the technology of the day - high standards of work in the company.

    Definition of success in Zahrawi Pharmacy Company is a definition other than the performance of the sales market and only quality is an integral part of the company's strategy. Because Zahrawi Pharmaceutical Company has understood well that the satisfaction of the people is the first condition of success.

    Zahrawi Pharmaceuticals as a pioneer company in the production of complementary medicines in Iran-as well as soft capsule drugs, while producing complementary medicines, seeks to complete a new portfolio of nephrology-dialysis and transplantation patients, and the production of biotechnology drugs and pharmaceuticals. It is somewhat valuable. Many of the research projects of this company are drugs that are being manufactured in the country for the first time.

    Zahrawi Pharmaceutical Company is the manufacturer of soft capsules in Iran and the Middle East and is currently the largest producer of gel drugs in the region.

    Close
certifictes
Products
Methyldopa
Montelukast
Zwitterol
Ketorolac Ampoules
Omega 3
ADVIFEN